How Should US FDA Navigate Thorny First Amendment Conundrums: Former Chief Counsels Offer Advice

Daniel Troy suggests FDA increase its investment in science of consumer understanding, while Richard Cooper recommends the "bully pulpit" approach to get industry's attention. A panel of former chief counsels stressed that the agency cannot continue to ignore First Amendment free speech issues.